Resources from leading medical experts from UCSF Medical Center
The UCSF Heart & Vascular Center brings together cardiologists, cardiac and vascular surgeons, interventional radiologists and other specialists to provide the most advanced and effective treatments, many of them developed right here at UCSF. We are tackling heart and vascular disease from several fronts — from prevention and screening to the newest treatments in cardiology and vascular surgery.
Latest Videos |view all videos
Clifton Watt, MD, explains that echocardiography is one of the most common noninvasive tools used in cardiology to date. While strain imaging is a supplementary way to assess myocardial function.
Cardiac imaging specialist Dr. Shafkat Anwar explains how MRI facilitates better management of patients born with heart defects, while technologies such as 3D printing can improve surgical planning, efficiency, outcomes and training.
With heart failure’s prevalence and poor prognosis, it’s important to understand the difference VADs can make. Cardiologist Dr. Liviu Klein discusses the latest devices, implantation techniques and monitoring methods, as well as outcomes and best candidates.
Vascular surgeon Dr. Charles Eichler discusses UCSF’s success with including vascular surgeons in lumbar fusion procedures and finding the least invasive approach for each patient.
Michael S. Conte, MD, provides an overview of the various noncardiac and extracranial blood vessel conditions treated by the Division of Vascular & Endovascular Surgery.
Tobias Deuse, MD, discusses the advantages of minimally invasive approaches for the treatment of mitral valve insufficiency.
Zian H. Tseng, MD, discusses the conclusions of the UCSF Prospective Countywide Surveillance and Autopsy Characterization of Sudden Cardiac Death (POST SCD) Study.
Vaikom Mahadevan, MD, discusses the history of transcatheter valve implants and their advantages, including less risk, less blood loss and shorter hospital stays.
Anita Moon-Grady, MD, FAAP, FACC, discusses congenital heart disease (CHD), the most common cause of infant death due to birth defect in the United States.
Articles & Documents
Diagnosing sarcoidosis is a challenging process. UCSF’s team of specialists are experts in diagnosing and treating this elusive chronic condition.
A new coronavirus, related to the SARS and MERS diseases that have caused epidemics, has been discovered in China and started to spread.
UCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.
The first and only dedicated amputation-prevention center in the Bay Area
A full range of therapeutic options – including evidence-based pharmacology, innovative devices and an experienced transplant program – offer personalized approaches to slow progression, prolong survival and improve quality of life